Oura Files for $2.2 Billion IPO Amid Expansion into Healthcare Features
Wearables company Oura has filed to raise up to $2.2 billion in an initial public offering (IPO), according to a recent securities filing. The firm plans to offer 13.5 million shares at an estimated price range of $40–$44 per share, with additional shares from selling stockholders bringing the total number offered to 50 million. Oura is going public as it expands into healthcare features and faces regulatory scrutiny over whether its products should be classified as medical devices or wellness tools. Oura currently markets smart rings that track activity, sleep, stress, and other health metrics but has not yet received FDA clearance for any of these functions as medical devices. The company is developing new capabilities such as nighttime blood pressure tracking and a tool to identify hidden hypertension risk, which may require regulatory approval in the future. Oura also recently added features allowing users to upload lab results and partnered with companies like Dexcom and ResMed. The IPO filing comes amid uncertainty around FDA guidance for wearables technology. Earlier this year, the agency revised its wellness exemption policy without prior notice, affecting how certain devices are classified.
Topics: IPO securities filing wearables industry